Neuroderm, Ltd.

Liat Adar

Itay Perlstein

Tal Birnberg

Natalia Vostokova

Laurence Salin

Nissim Sasson

Shmuel Ben Eliahu

Mikio Himizu

Danit Finkelshtein Beker

Hikari Yarita

Sheila Oren

Tamar Yardeni

Nelson Felix Lopes

Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in a patient in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof.

Methods and compositions for reducing symptoms of Parkinson's disease

Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa, a levodopa salt, a levodopa prodrug, or any combination thereof, and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, a carbidopa salt, a carbidopa prodrug, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.

Methods for treatment of Parkinson's disease

Disclosed is a method for the treatment of a neurological or movement disorder, e.g., Parkinson's disease, in an individual in need thereof, by parenteral administration of levodopa and a dopa decarboxylase inhibitor (DDCI), such as carbidopa, benserazide or any combination thereof, concomitantly with oral administration of levodopa, a DDCI, such as carbidopa, benserazide, or any combination thereof.

Method for treatment of Parkinson's disease

Method for treatment of parkinson's disease

Growing community of inventors

Rehovot, Israel

Liat Adar